Search

Vetoquinol SA

Slēgts

SektorsVeselības aprūpe

78.2 -0.13

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

76.8

Max

78.3

Galvenie mērījumi

By Trading Economics

Ienākumi

-9.8M

25M

Pārdošana

-17M

258M

P/E

Sektora vidējais

14.961

36.442

Dividenžu ienesīgums

1.16

Peļņas marža

9.734

Darbinieki

2,497

EBITDA

-12M

48M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.16%

3.00%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

14M

924M

Iepriekšējā atvēršanas cena

78.33

Iepriekšējā slēgšanas cena

78.2

Ziņu noskaņojums

By Acuity

50%

50%

159 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Vetoquinol SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. okt. 18:13 UTC

Galvenie tirgus virzītāji

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

2025. g. 17. okt. 17:05 UTC

Galvenie tirgus virzītāji

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

2025. g. 17. okt. 15:03 UTC

Galvenie tirgus virzītāji

Obook Shares Sink Following Public Debut

2025. g. 17. okt. 14:41 UTC

Galvenie tirgus virzītāji

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

2025. g. 17. okt. 23:25 UTC

Iegādes, apvienošanās, pārņemšana

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

2025. g. 17. okt. 22:15 UTC

Tirgus saruna

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

2025. g. 17. okt. 21:15 UTC

Tirgus saruna

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

2025. g. 17. okt. 21:07 UTC

Tirgus saruna

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

2025. g. 17. okt. 21:07 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 17. okt. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 17. okt. 20:34 UTC

Tirgus saruna

Deere Is Reaching the End of Its Downcycle -- Market Talk

2025. g. 17. okt. 20:27 UTC

Tirgus saruna

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

2025. g. 17. okt. 19:46 UTC

Tirgus saruna

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

2025. g. 17. okt. 19:45 UTC

Tirgus saruna

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

2025. g. 17. okt. 18:45 UTC

Tirgus saruna

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

2025. g. 17. okt. 17:51 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. okt. 17:51 UTC

Tirgus saruna

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

2025. g. 17. okt. 17:44 UTC

Tirgus saruna

EQT Seen With Long-Term Growth Opportunities -- Market Talk

2025. g. 17. okt. 17:35 UTC

Tirgus saruna

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

2025. g. 17. okt. 16:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 17. okt. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 17. okt. 16:14 UTC

Tirgus saruna

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

2025. g. 17. okt. 16:04 UTC

Tirgus saruna

Home Improvement Demand Is Starting to Pick Up -- Market Talk

2025. g. 17. okt. 15:58 UTC

Tirgus saruna

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

2025. g. 17. okt. 15:56 UTC

Peļņas

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

2025. g. 17. okt. 15:43 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 17. okt. 15:43 UTC

Tirgus saruna

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

2025. g. 17. okt. 14:58 UTC

Tirgus saruna

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

2025. g. 17. okt. 14:41 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. okt. 14:35 UTC

Tirgus saruna
Peļņas

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Vetoquinol SA Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

72.6 / 75.1Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

159 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat